116 related articles for article (PubMed ID: 21059769)
1. A panel of human cell-based artificial APC enables the expansion of long-lived antigen-specific CD4+ T cells restricted by prevalent HLA-DR alleles.
Butler MO; Ansén S; Tanaka M; Imataki O; Berezovskaya A; Mooney MM; Metzler G; Milstein MI; Nadler LM; Hirano N
Int Immunol; 2010 Nov; 22(11):863-73. PubMed ID: 21059769
[TBL] [Abstract][Full Text] [Related]
2. One-step shotgun approach for antigenic specific pMHCs capture stimulated CD8
Liu L; Li Y; Song Y; Sun Z; Li W; Li B; Wang Y; Wang H; Wang B
Cell Immunol; 2023; 393-394():104784. PubMed ID: 37984278
[TBL] [Abstract][Full Text] [Related]
3. Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansion.
Oelke M; Schneck JP
Immunol Res; 2010 Jul; 47(1-3):248-56. PubMed ID: 20087680
[TBL] [Abstract][Full Text] [Related]
4. Shape matters: Biodegradable anisotropic nanoparticle artificial antigen presenting cells for cancer immunotherapy.
Ben-Akiva E; Hickey JW; Meyer RA; Isser A; Shannon SR; Livingston NK; Rhodes KR; Kosmides AK; Warren TR; Tzeng SY; Schneck JP; Green JJ
Acta Biomater; 2023 Apr; 160():187-197. PubMed ID: 36812956
[TBL] [Abstract][Full Text] [Related]
5. Artificial Antigen-Presenting Cell Fabrication for Murine T Cell Expansion.
Omotoso MO; Lanis MR; Schneck JP
Curr Protoc; 2024 Feb; 4(2):e976. PubMed ID: 38400601
[TBL] [Abstract][Full Text] [Related]
6. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells.
Sunshine JC; Perica K; Schneck JP; Green JJ
Biomaterials; 2014 Jan; 35(1):269-277. PubMed ID: 24099710
[TBL] [Abstract][Full Text] [Related]
7. Cell-Sized Lipid Vesicles as Artificial Antigen-Presenting Cells for Antigen-Specific T Cell Activation.
Chen JY; Agrawal S; Yi HP; Vallejo D; Agrawal A; Lee AP
Adv Healthc Mater; 2023 May; 12(12):e2203163. PubMed ID: 36645182
[TBL] [Abstract][Full Text] [Related]
8. Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.
Liu SQ; Liu LS; Ohno T
Cytotechnology; 1998 Jan; 26(1):13-21. PubMed ID: 22359002
[TBL] [Abstract][Full Text] [Related]
9. Re-centauring T cell antigen discovery around CD4
Smith BE; Chan AO; Birnbaum ME
Cell Rep Methods; 2024 Jan; 4(1):100694. PubMed ID: 38262348
[TBL] [Abstract][Full Text] [Related]
10. Evidence for antigen presentation by human neutrophils.
Moffat A; Gwyer Findlay E
Blood; 2024 Mar; ():. PubMed ID: 38498044
[TBL] [Abstract][Full Text] [Related]
11. Human cell-based artificial antigen-presenting cells for cancer immunotherapy.
Butler MO; Hirano N
Immunol Rev; 2014 Jan; 257(1):191-209. PubMed ID: 24329798
[TBL] [Abstract][Full Text] [Related]
12. Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.
Forget MA; Malu S; Liu H; Toth C; Maiti S; Kale C; Haymaker C; Bernatchez C; Huls H; Wang E; Marincola FM; Hwu P; Cooper LJ; Radvanyi LG
J Immunother; 2014; 37(9):448-60. PubMed ID: 25304728
[TBL] [Abstract][Full Text] [Related]
13. Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells.
Butler MO; Friedlander P; Milstein MI; Mooney MM; Metzler G; Murray AP; Tanaka M; Berezovskaya A; Imataki O; Drury L; Brennan L; Flavin M; Neuberg D; Stevenson K; Lawrence D; Hodi FS; Velazquez EF; Jaklitsch MT; Russell SE; Mihm M; Nadler LM; Hirano N
Sci Transl Med; 2011 Apr; 3(80):80ra34. PubMed ID: 21525398
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells.
Nakatsugawa M; Rahman MA; Yamashita Y; Ochi T; Wnuk P; Tanaka S; Chamoto K; Kagoya Y; Saso K; Guo T; Anczurowski M; Butler MO; Hirano N
Sci Rep; 2016 Mar; 6():23821. PubMed ID: 27030642
[TBL] [Abstract][Full Text] [Related]
15. Linking form to function: Biophysical aspects of artificial antigen presenting cell design.
Perica K; Kosmides AK; Schneck JP
Biochim Biophys Acta; 2015 Apr; 1853(4):781-90. PubMed ID: 25200637
[TBL] [Abstract][Full Text] [Related]
16. Transient stimulation expands superior antitumor T cells for adoptive therapy.
Kagoya Y; Nakatsugawa M; Ochi T; Cen Y; Guo T; Anczurowski M; Saso K; Butler MO; Hirano N
JCI Insight; 2017 Jan; 2(2):e89580. PubMed ID: 28138559
[TBL] [Abstract][Full Text] [Related]
17. NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data.
Jurtz V; Paul S; Andreatta M; Marcatili P; Peters B; Nielsen M
J Immunol; 2017 Nov; 199(9):3360-3368. PubMed ID: 28978689
[TBL] [Abstract][Full Text] [Related]
18. Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.
Rasmussen M; Harndahl M; Stryhn A; Boucherma R; Nielsen LL; Lemonnier FA; Nielsen M; Buus S
J Immunol; 2014 Nov; 193(10):4790-802. PubMed ID: 25311805
[TBL] [Abstract][Full Text] [Related]
19. Antigenic Peptide-Thioredoxin Fusion Chimeras for In Vitro Stimulus of CD4
Ishina IA; Zakharova MY; Kurbatskaia IN; Mamedov AE; Belogurov AA; Rubtsov YP; Gabibov AG
Dokl Biochem Biophys; 2024 Jun; 516(1):53-57. PubMed ID: 38700816
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
